THE NEWER MACROLIDES
- 1 September 1995
- journal article
- Published by Elsevier BV in Infectious Disease Clinics of North America
- Vol. 9 (3), 731-745
- https://doi.org/10.1016/s0891-5520(20)30694-2
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Clinical trial of clarithromycin for lepromatous leprosyAntimicrobial Agents and Chemotherapy, 1994
- Clarithromycin 250 mg b. i. d. for 5 or 10 days in the treatment of adult patients with purulent bronchitisInfection, 1993
- Mycobacterium avium Complex Infection and AIDS: Advances in Theory and PracticeClinical Infectious Diseases, 1993
- Treatment of Community-acquired PneumoniaChest, 1993
- Comparison of azithromycin versus clarithromycin in the treatment of patients with lower respiratory tract infectionJournal of Antimicrobial Chemotherapy, 1993
- Azithromycin: The First Azalide AntibioticAnnals of Pharmacotherapy, 1992
- Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC systemAntimicrobial Agents and Chemotherapy, 1992
- Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organismsAntimicrobial Agents and Chemotherapy, 1992
- Activity of Clarithromycin againstMycobacterium aviumInfection in Patients with the Acquired Immune Deficiency Syndrome: A Controlled Clinical TrialAmerican Review of Respiratory Disease, 1991
- Interpretative criteria for the agar diffusion susceptibility test with azithromycinJournal of Antimicrobial Chemotherapy, 1988